Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation

Biological Chemistry

Volumn 378, Issue 3-4, 1997, Pages 265-271

  Emonard, Hervé ^a   Hornebeck, William ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Activation; Elastin; Progelatinases

Indexed keywords

BATIMASTAT; EDETIC ACID; ELASTIN; ENZYME ACTIVATOR; ENZYME PRECURSOR; GELATINASE; KALLIKREIN; LEUKOCYTE ELASTASE; PLASMIN; PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTERIOSCLEROSIS; ARTERY WALL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME RELEASE; ENZYME SUBSTRATE COMPLEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION;

EID: 0030907533     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1997.378.3-4.265     Document Type: Article

References (29)

1. Allan, J.A., Docherty, A.J.R, Barker, P.J., Huskisson, N.S., Reynolds, J.J., and Murphy, G. (1995). Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem. J. 309, 299-306.
2. Banyai, L., Tordai, H., and Patthy, L. (1996). Structure and domain-domain interactions of the gelatin-binding site of human 72 kilodalton type IV collagenase (gelatinase A, matrix metallo-proteinase 2). J. Biol. Chem. 271, 12003-12008.
3. Beranger, J.Y., Godeau, G., Frances, C., Robert, L., and Hornebeck, W. (1994). Presence of gelatinase A and metalloelastase type protease at the plasma membrane of human skin fibroblasts. Influence of cytokines and growth factors on cell-associated metalloendopeptidase levels. Cell. Biol. Int. 18, 715-722.
4. Bieth, J.G. (1986). Elastase: catabolic properties. In: Biology of Extracellular Matrix: Regulation of Matrix Accumulation, R.P. Mecham, ed. (New York, USA: Academic Press), pp. 217-320.
5. Crabbe, T., loannou, C., and Docherty, A.J.P. (1993). Human progelatinase A can be activated by autolysis at a rate that is concentration dependent and enhanced by heparin bound to the C-terminal domain. Eur. J. Biochem. 278, 431-438.
6. Davies, B., Brown, P.D., East, N., Crimmin, M.J., and Balkwill, F.R. (1993). A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53, 2087-2091.
7. Hornebeck, W., and Schnebli, H.R (1982). Effect of different elastase inhibitors on leukocyte elastase preadsorbed to elastin. Hoppe-Seyler's Z. Physiol. Chem. 363, 455-458.
8. Hornebeck, W., Adnet, J.J., and Robert, L. (1978). Age dependent variation of elastin and elastase in aorta and human breast cancers. Exp. Gerontol. 13, 293-298.
9. Hornebeck, W., Tixier, J.M., and Robert, L. (1986). Inducible adhesion of mesenchymal cells to elastic fibers: elastonectin. Proc. Natl. Acad. Sci. USA 83, 5517-5520.
10. Hornebeck, W., and Robert, L. (1987a). Biosynthesis and degradation of elastin. In: Vascular Smooth Muscle in Culture, J.H. Campbell and G.R. Campbell, eds. (Boca Rato, USA: CRC Press), pp. 1-30.
11. Hornebeck, W., and Robert, L. (1987b). Transition of smooth muscle cells from the quiescent to the proliferative form. Role of elastonectin and plasma membrane elastase-type protease. In: Cardiovascular Disease. Molecular and Cellular Mechanisms, Prevention, and Treatment, L.L. Gallo, ed. (New York, USA: Plenum Press), pp. 219-225.
12. Jacob, M.P., and Hornebeck, W. (1985). Isolation and characterization of insoluble and kappa-elastins. Front. Matrix Biol. 70, 92-129.
13. Keski-Oja, J., Lohi, J., Tuuttila, A., Tryggvason, K., and Vartio, T. (1992). Proteolytic processing of the 72,000 type IV collagenase by urokinase plasminogen activator. Exp. Cell Res. 202, 471-476.
14. Knight, G.G., Willenbrock, F., and Murphy, G. (1992). A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296, 263-266.
15. Koklitis, P.A., Murphy, G., Sutton, C., and Angal, S. (1991). Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities. Biochem. J. 276, 217-221.
16. Michaelis, J., Vissers, M.C., and Winterbourn, C.C. (1992). Different effects of hypochlorous acid on human neutrophil metalloproteinases: activation of collagenase and inactivation of collagenase and gelatinase. Arch. Biochem. Biophys. 292, 555-562.
17. Noël, A.C., Polette, M., Lewalle, J.M., Munaut, C., Emonard, H.P., Birembaut, P., and Foidart, J.M. (1994). Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells. Int. J. Cancer 56, 331-336.
18. Okada, Y., Katsuda, S., Okada, Y., and Nakanishi, I. (1993). An elastinolytic enzyme detected in the culture medium of human arterial smooth muscle cells. Cell. Biol. Int. 17, 863-869.
19. Patel, M.I., Melrose, J., Ghosh, P., and Appleberg, M. (1996). Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J. Vasc. Surg. 24, 82-92.
20. Peppin, G.J., and Weiss, S.J. (1986). Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc. Natl. Acad. Sci. USA 83, 4322-4326.
21. Robert, B., Hornebeck, W., and Robert, L. (1974). Cinétique hétérogène de l'interaction élastine-élastase. Biochimie 56, 239-244.
22. Robert, L, Jacob, M.P., and Robert, A.M. (1992). The elastic element of the arterial wall. Biosynthesis and interactions between elastin and cells. In: Interzellularsubstanz in der Gefäßwand, E. Betz and D. Kling, eds. (Tübingen, Germany: Attempto Verlag), pp. 9-21.
23. Sato, H., and Seiki, M. (1996). Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J. Biochem. 119, 209-215.
24. Senior, R.M., Griffin, G.L., Fliszar, C.J., Shapiro, S.D., Goldberg, G.I., and Welgus, H.G. (1991). Human 92 and 72 kilodalton type IV collagenases are elastases. J. Biol. Chem. 266, 7870-7875.
25. Shapiro, S.D., Fliszar, C.J., Broekelmann, T.J., Mecham, R.P., Senior, R.M., and Welgus, H.G. (1995). Activation of the 92 kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyterminal domain by tissue inhibitor of metalloproteinases (TIMP). J. Biol. Chem. 270, 6351-6356.
26. Shipley, J.M., Doyle, G.A.R., Fliszar, C.J., Ye, Q-Z., Johnson, L.L., Shapiro, S.D., Welgus, H.G., and Senior, R.M. (1996). The structural basis for the elastolytic activity of the 92 kDa and 72 kDa gelatinases. Role of the fibronectin type II-like repeats. J. Biol. Chem. 277, 4335-4341.
27. Woessner, J.F. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145-2154.
28. Yanagi, H., Sasaguri, Y., Sugama, K., Morimatsu, M., and Nagase, H. (1992). Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis 91, 207-216.
29. Zempo, N., Koyama, N., Kenagy, R.D., Lea, H.J., and Clowes, A. W. (1996). Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler. Thromb. Vasc. Biol. 16, 28-33.